Trial Profile

Ulipristal versus standard surgical treatment in symptomatic uterine fibroids

Status: Recruiting

Phase of Trial: Phase IV

Latest Information Update: 21 Jun 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Ulipristal (Primary)
Indications Uterine leiomyoma
Focus Therapeutic Use
Acronyms MYOMEX-2

Most Recent Events

21 Jun 2021 Status changed from suspended to recruiting.
01 Jan 2021 Trial design of MYOMEX 2 study investigating effectiveness and cost-effectiveness of long term UPA administration in comparison to standard surgical treatment for patients with symptomatic uterine fibroids published in the European Journal of Obstetrics and Gynecology and Reproductive Biology
16 Nov 2020 Status changed from recruiting to suspended.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com